DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Schroth W, Hamann U, Fasching PA. et al.
CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification.
Clin Cancer Res 2010;
16: 4468-4477
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.